Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF) (2019 - 2026)

Praxis Precision Medicines' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $39000.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 17.02% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $92000.0, a 68.6% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 72.07% from the prior year.
• Depreciation & Amortization (CF) advanced to $39000.0 in Q1 2026 per PRAX's latest filing, from -$12000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $119000.0 in Q2 2022 and bottomed at -$12000.0 in Q4 2025.
• The 5-year median for Depreciation & Amortization (CF) is $92000.0 (2024), against an average of $76294.1.
• Across the five-year window, Depreciation & Amortization (CF) jumped 340.74% in 2022 and slumped 125.53% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $86000.0 in 2022, then retreated by 8.14% to $79000.0 in 2023, then sank by 40.51% to $47000.0 in 2024, then slumped by 125.53% to -$12000.0 in 2025, then soared by 425.0% to $39000.0 in 2026.
• Per Business Quant, the three latest PRAX Depreciation & Amortization (CF) figures stand at $39000.0 (Q1 2026), -$12000.0 (Q4 2025), and $19000.0 (Q3 2025).